Share:
Peer-Reviewed Publication
J Manag Care Spec Pharm2023;29(4):378-390.April 1, 2023Observational Study

Increased delay from initial concern to diagnosis of autism spectrum disorder and associated health care resource utilization and cost among children aged younger than 6 years in the United States.

Michelle Vu1, Amy M Duhig2, Abhishek Tibrewal3, Chelsey M Campbell2, Abhishek Gaur3, Carmela Salomon4, Ankita Gupta5, Morgan Kruse6, Sharief Taraman4,7,8,9
1Value-Based Contracting and Health Economics and Outcomes Research, Cognoa, Inc.
2Market Access and Value Evidence, Cognoa, Inc.
3Commercial Analytics, Optum.
4Medical Affairs, Cognoa, Inc.
5Statistics, Commercial Analytics, Optum.
6Value-Based Contracting, Optum.
7Dale E and Sarah Ann Fowler School of Engineering, Chapman University, Orange, CA.
8Children's Health of Orange County, CA.
9Department of Pediatrics, Irvine School of Medicine, University of California.

Abstract

BACKGROUND: Prolonged delays between first caregiver concern and autism spectrum disorder (ASD) diagnosis have been reported, but associations between length of time to diagnosis (TTD) and health care resource utilization (HCRU) and costs have not been studied in a large sample of children with ASD. OBJECTIVE: To address these informational gaps in the ASD diagnostic pathway. METHODS: This retrosp…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.